Page last updated: 2024-12-07
thiophene a
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
thiophene A: RN not in Chemline 4/87; RN from Chem Abstracts Index Guide 1986; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 100448 |
SCHEMBL ID | 22733849 |
MeSH ID | M0147173 |
Synonyms (19)
Synonym |
---|
thiophene a |
nsc-302303 |
nsc302303 |
2134-99-8 |
bohlmann k4018 |
2-hex-5-en-1,3-diynyl-5-prop-1-ynylthiophene |
y5ixf40lug , |
thiophene-a |
nsc 302303 |
thiophene, 2-(5-hexene-1,3-diynyl)-5-(1-propynyl)- |
unii-y5ixf40lug |
DTXSID20175608 |
2-(hexa-5-en-1,3-diyn-1-yl)-5-(prop-1-yn-1-yl)thiophene |
LMFA12000347 |
2-(hexa-5-en-1,3-diynyl)-5-(propynyl)-thiophene |
thiophene, 2-(5-hexene-1,3-diyn-1-yl)-5-(1-propyn-1-yl)- |
2-(5-hexene-1,3-diyn-1-yl)-5-(1-propyn-1-yl)thiophene |
thiophene, 2-(5-hexen-1,3-diynyl)-5-(1-propynyl)- |
SCHEMBL22733849 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.30
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.30) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (10.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (90.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |